125 related articles for article (PubMed ID: 26564903)
1. Osteoclast activation and sickle bone disease.
Gordeuk VR
Blood; 2015 Nov; 126(20):2259-60. PubMed ID: 26564903
[No Abstract] [Full Text] [Related]
2. Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease.
Dalle Carbonare L; Matte' A; Valenti MT; Siciliano A; Mori A; Schweiger V; Zampieri G; Perbellini L; De Franceschi L
Blood; 2015 Nov; 126(20):2320-8. PubMed ID: 26330244
[TBL] [Abstract][Full Text] [Related]
3. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
Hebbel RP; Osarogiagbon R; Kaul D
Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
[TBL] [Abstract][Full Text] [Related]
4. Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.
Chirico EN; Faës C; Connes P; Canet-Soulas E; Martin C; Pialoux V
Sports Med; 2016 May; 46(5):629-39. PubMed ID: 26666745
[TBL] [Abstract][Full Text] [Related]
5. Osteoclastogenesis and osteoclast activation in dialysis-related amyloid osteopathy.
Kazama JJ; Maruyama H; Gejyo F
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S156-60. PubMed ID: 11576944
[TBL] [Abstract][Full Text] [Related]
6. [Bone and joint manifestations of sickle cell anemia].
Hernigou P
Acta Orthop Belg; 1999; 65 Suppl 1():9-16. PubMed ID: 10084211
[No Abstract] [Full Text] [Related]
7. Induced expression of bone morphogenetic protein-6 and Smads signaling in human monocytes derived dendritic cells during sickle-cell pathology with orthopedic complications.
Abhishek K; Kumar R; Arif E; Patra PK; Choudhary SB; Sohail M
Biochem Biophys Res Commun; 2010 Jun; 396(4):950-5. PubMed ID: 20460105
[TBL] [Abstract][Full Text] [Related]
8. Role of oxidative stress in the pathogenesis of sickle cell disease.
Chirico EN; Pialoux V
IUBMB Life; 2012 Jan; 64(1):72-80. PubMed ID: 22131167
[TBL] [Abstract][Full Text] [Related]
9. Exacerbated metabolic changes in skeletal muscle of sickle cell mice submitted to an acute ischemia-reperfusion paradigm.
Chatel B; Messonnier LA; Vilmen C; Bernard M; Pialoux V; Bendahan D
Clin Sci (Lond); 2018 Oct; 132(19):2103-2115. PubMed ID: 30185507
[TBL] [Abstract][Full Text] [Related]
10. Osteoclastic microRNAs and their translational potential in skeletal diseases.
Inoue K; Nakano S; Zhao B
Semin Immunopathol; 2019 Sep; 41(5):573-582. PubMed ID: 31591677
[TBL] [Abstract][Full Text] [Related]
11. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.
O'Keefe RJ; Teot LA; Singh D; Puzas JE; Rosier RN; Hicks DG
Lab Invest; 1997 Apr; 76(4):457-65. PubMed ID: 9111508
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptor-alpha in cells of the osteoclastic lineage.
Oreffo RO; Kusec V; Virdi AS; Flanagan AM; Grano M; Zambonin-Zallone A; Triffitt JT
Histochem Cell Biol; 1999 Feb; 111(2):125-33. PubMed ID: 10090573
[TBL] [Abstract][Full Text] [Related]
13. Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain.
Hebbel RP
Hematol Oncol Clin North Am; 2014 Apr; 28(2):181-98. PubMed ID: 24589261
[TBL] [Abstract][Full Text] [Related]
14. RANKL-RANK signaling in osteoclastogenesis and bone disease.
Wada T; Nakashima T; Hiroshi N; Penninger JM
Trends Mol Med; 2006 Jan; 12(1):17-25. PubMed ID: 16356770
[TBL] [Abstract][Full Text] [Related]
15. Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.
Nakayachi M; Ito J; Hayashida C; Ohyama Y; Kakino A; Okayasu M; Sato T; Ogasawara T; Kaneda T; Suda N; Sawamura T; Hakeda Y
Bone; 2015 Jun; 75():170-82. PubMed ID: 25744064
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and management of myeloma bone disease.
Christoulas D; Terpos E; Dimopoulos MA
Expert Rev Hematol; 2009 Aug; 2(4):385-98. PubMed ID: 21082944
[TBL] [Abstract][Full Text] [Related]
17. The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition "Killing Two Birds with One Stone"?
Jimi E; Takakura N; Hiura F; Nakamura I; Hirata-Tsuchiya S
Cells; 2019 Dec; 8(12):. PubMed ID: 31847314
[TBL] [Abstract][Full Text] [Related]
18. The osteoclast: friend or foe?
Novack DV; Teitelbaum SL
Annu Rev Pathol; 2008; 3():457-84. PubMed ID: 18039135
[TBL] [Abstract][Full Text] [Related]
19. Bone disease and cytokines in idiopathic hypercalciuria: a review.
Santos AC; Lima EM; Oliveira EA; Simões e Silva AC
J Pediatr Endocrinol Metab; 2011; 24(7-8):405-10. PubMed ID: 21932573
[TBL] [Abstract][Full Text] [Related]
20. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.
Faict S; Muller J; De Veirman K; De Bruyne E; Maes K; Vrancken L; Heusschen R; De Raeve H; Schots R; Vanderkerken K; Caers J; Menu E
Blood Cancer J; 2018 Nov; 8(11):105. PubMed ID: 30409995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
